about
Inter-individual diversity and intra-individual stability of amphetamine-induced sensitization of frequency-modulated 50-kHz vocalization in Sprague-Dawley ratsThe kynurenine pathway: a missing piece in the puzzle of valproate action?The effects of group III mGluR ligands on pentylenetetrazol-induced kindling of seizures and hippocampal amino acids concentration.Low-anxiety rats are more sensitive to amphetamine in comparison to high-anxiety rats.GABAergic control of the activity of the central nucleus of the amygdala in low- and high-anxiety rats.N-acetyl cysteine does not modify the sensitization of the rewarding effect of amphetamine as assessed with frequency-modulated 50-kHz vocalization in the rat.Midazolam treatment before re-exposure to contextual fear reduces freezing behavior and amygdala activity differentially in high- and low-anxiety rats.κ-opioid receptor as a key mediator in the regulation of appetitive 50-kHz ultrasonic vocalizations.Differences in the density of GABA-A receptor alpha-2 subunits and gephyrin in brain structures of rats selected for low and high anxiety in basal and fear-stimulated conditions, in a model of contextual fear conditioning.The effects of acute and chronic administration of corticosterone on rat behavior in two models of fear responses, plasma corticosterone concentration, and c-Fos expression in the brain structures.Fluoxetine attenuates the effects of pentylenetetrazol on rat freezing behavior and c-Fos expression in the dorsomedial periaqueductal gray.The effect of chronic administration of corticosterone on anxiety- and depression-like behavior and the expression of GABA-A receptor alpha-2 subunits in brain structures of low- and high-anxiety rats.Midazolam inhibits neophobia-induced Fos expression in the rat hippocampus.The localization of brain sites of anxiogenic-like effects of urocortin-2.Effects of morphine and methadone treatment on mRNA expression of Gα(i) subunits in rat brains.The effects of midazolam and D-cycloserine on the release of glutamate and GABA in the basolateral amygdala of low and high anxiety rats during extinction trial of a conditioned fear test.The influence of the long-term administration of Curcuma longa extract on learning and spatial memory as well as the concentration of brain neurotransmitters and level of plasma corticosterone in aged rats.Mapping of c-Fos expression in the rat brain during the evolution of pentylenetetrazol-kindled seizures.The influence of CRF and alpha-helical CRF(9-41) on rat fear responses, c-Fos and CRF expression, and concentration of amino acids in brain structures.The role of the dorsomedial part of the prefrontal cortex serotonergic innervation in rat responses to the aversively conditioned context: behavioral, biochemical and immunocytochemical studies.Effects of pentylenetetrazol-induced kindling of seizures on rat emotional behavior and brain monoaminergic systems.Changes in the brain expression of alpha-2 subunits of the GABA-A receptor after chronic restraint stress in low- and high-anxiety rats.Stress-opioid interactions: a comparison of morphine and methadone.Rat behavior in two models of anxiety and brain [3H]muscimol binding: pharmacological, correlation, and multifactor analysis.Hippocampal mGluR1 and consolidation of contextual fear conditioning.Morphine and methadone pre-exposures differently modify brain regional Fos protein expression and locomotor activity responses to morphine challenge in the rat.The effect of fluoxetine in a model of chemically induced seizures--behavioral and immunocytochemical study.Corticosterone modulates fear responses and the expression of glucocorticoid receptors in the brain of high-anxiety rats.Methadone is substantially less effective than morphine in modifying locomotor and brain Fos responses to subsequent methadone challenge in rats.The effect of CRF and alpha-helical CRF((9-41)) on rat fear responses and amino acids release in the central nucleus of the amygdala.Time course of changes in the concentration of kynurenic acid in the brain of pentylenetetrazol-kindled rats.Changes in the concentration of amino acids in the hippocampus of pentylenetetrazole-kindled rats.Buspirone attenuates conditioned fear-induced c-Fos expression in the rat hippocampus.Expression of c-Fos and CRF in the brains of rats differing in the strength of a fear response.The co-expression of GluN2B subunits of the NMDA receptors and glucocorticoid receptors after chronic restraint stress in low and high anxiety rats.Behavioral effects and CRF expression in brain structures of high- and low-anxiety rats after chronic restraint stress.Chronic restraint increases apoptosis in the hippocampus of rats with high responsiveness to fear stimuli.High-anxiety rats are less sensitive to the rewarding affects of amphetamine on 50kHz USV.Colocalisation of c-Fos and glucocorticoid receptor as well as of 5-HT(1A) and glucocorticoid receptor immunoreactivity-expressing cells in the brain structures of low and high anxiety rats.The effects of acute corticosterone administration on anxiety, endogenous corticosterone, and c-Fos expression in the rat brain.
P50
Q30465499-288C860C-C7DA-4CB7-9425-BEA2E1E0F631Q33355026-C01A0AB5-2518-47D6-B811-A6015BFF6A6EQ34983905-40FC03CD-BBAC-48CD-85A3-296C88FF71D6Q39323098-F1E57473-FDA0-4D44-8553-897CC8D59558Q40595877-EE44BB83-469C-475E-94CB-78BEE2ECCF1BQ41702938-6ABF1513-92F6-45DD-9047-AB6407F02296Q41720208-14FC662F-BB6E-4828-BA93-8A41D1185028Q41735843-47BFCEAE-E4B5-4BE1-8C0E-C6D09316EDDDQ42476879-FEC60818-FE01-4CCB-ACE5-493AA7AE1190Q42603589-D03D0EE5-4B37-4278-AAC4-4B9C63C145ACQ42608268-D821D0D1-8488-4F7A-BEB3-E1790D10286CQ42626810-F8A073BB-C921-48D3-8C66-36E720496E0FQ42676399-CE24A88A-C199-48A8-900F-39302180ABE3Q42683650-A511D6EE-0F0A-48FD-9ADA-9E03FC82922CQ42754352-8A4C6248-4060-4FB5-9A7E-3B4A38E1EC3BQ42921123-47242DFA-D873-4967-945F-EF644BDF2738Q43135010-6D9954C8-C537-48A5-9DC6-CA194988D00AQ43284630-0A1CAFA8-C63B-47F9-A7FA-251E64FE65BCQ43498132-0E166281-347C-4427-9FF3-9A13FA683057Q44083281-41B43231-A243-421C-AFE9-0E419BB08744Q44126678-DD70365F-BC3B-4A36-A572-B47EE559BB51Q44131173-F4D44C48-DD40-43A5-A22D-DCB7EC8A54CFQ44343438-0723C4F1-87D3-4191-BEDA-446E56555C19Q44608546-F9B0D683-40E1-49B4-A4EF-0827A02DF98BQ44641447-6130CEA4-9A2F-4EC4-9DE9-F431C066DD0AQ44715345-D24A7649-1998-440B-8854-D5281505689BQ45201860-FF76A70F-0CBD-46AD-97EB-8124722236C3Q45842039-62BB083E-5C86-427F-906E-0D90DB57D53AQ45990059-ED320C98-A744-40BA-AC21-582A4D772210Q45992330-97931B00-2522-4997-B814-6180C3737BA5Q46233106-60A3BC1C-C32F-49E6-B5F7-995713DAA92CQ46555786-80F7C45C-6423-46DB-98F5-022C6091E75CQ46646373-72D7B116-6577-462C-A932-EBA88DB1D7CEQ46859431-0E51A891-6B0A-4A67-9C41-F047DEB2CC9AQ47370810-AE5B2C10-CA85-4AD4-BB5A-6D939EA53209Q47430730-D77A9597-2551-45E9-85E2-1E0C711B4B9DQ47775248-280F5F01-3A0B-4883-904A-FE5FADE933BDQ47813119-E832C22E-94C7-4F8F-B212-9983ED81364BQ47992340-4D0EEC4A-AC9C-4AF0-A0E5-C915164DF2E1Q48124915-096CDEE3-897A-4805-B0ED-8C1ABF335281
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Małgorzata H Lehner
@ast
Małgorzata H Lehner
@en
Małgorzata H Lehner
@es
Małgorzata H Lehner
@nl
Małgorzata Lehner
@pl
type
label
Małgorzata H Lehner
@ast
Małgorzata H Lehner
@en
Małgorzata H Lehner
@es
Małgorzata H Lehner
@nl
Małgorzata Lehner
@pl
prefLabel
Małgorzata H Lehner
@ast
Małgorzata H Lehner
@en
Małgorzata H Lehner
@es
Małgorzata H Lehner
@nl
Małgorzata Lehner
@pl
P214
P106
P1153
7004925485
P214
P31
P3124
P496
0000-0003-2154-8422
P7859
viaf-311808793